Clicky

Virios Therapeutics, Inc.(VIRI)

Description: Virios Therapeutics, LLC, a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, LLC in July 2020. Virios Therapeutics, LLC was founded in 2012 and is headquartered in Alpharetta, Georgia.


Keywords: Biotechnology Disease Rheumatology Fibromyalgia Antiviral Therapies

Home Page: www.virios.com

VIRI Technical Analysis

44 Milton Avenue
Alpharetta, GA 30009
United States
Phone: 866 620 8655


Officers

Name Title
Mr. Gregory Duncan Chairman & CEO
Mr. Ralph D. Grosswald M.P.H. Sr. VP of Operations
Dr. R. Michael Gendreau M.D., Ph.D. Chief Medical Officer
Ms. Angela Walsh CFO, SVP of Fin., Corp. Sec. & Treasurer
Ms. Carol Duffy Ph.D. Chief Scientific Advisor

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.4988
Price-to-Sales TTM: 0
IPO Date: 2020-12-17
Fiscal Year End: December
Full Time Employees: 5
Back to stocks